

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | platelet dense granule organization (GO:0060155) | 6.32339828 |
| 2 | ribosomal small subunit assembly (GO:0000028) | 6.26053733 |
| 3 | viral transcription (GO:0019083) | 6.20074528 |
| 4 | translational termination (GO:0006415) | 5.84930678 |
| 5 | DNA unwinding involved in DNA replication (GO:0006268) | 5.62817510 |
| 6 | regulation of respiratory burst (GO:0060263) | 5.39067914 |
| 7 | ribosomal small subunit biogenesis (GO:0042274) | 5.38134299 |
| 8 | indole-containing compound catabolic process (GO:0042436) | 5.05477530 |
| 9 | indolalkylamine catabolic process (GO:0046218) | 5.05477530 |
| 10 | tryptophan catabolic process (GO:0006569) | 5.05477530 |
| 11 | endosome to pigment granule transport (GO:0043485) | 5.03313878 |
| 12 | endosome to melanosome transport (GO:0035646) | 5.03313878 |
| 13 | translational elongation (GO:0006414) | 5.02961042 |
| 14 | negative regulation of epidermal cell differentiation (GO:0045605) | 4.98173613 |
| 15 | proline biosynthetic process (GO:0006561) | 4.89474525 |
| 16 | protein localization to kinetochore (GO:0034501) | 4.79783702 |
| 17 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 4.79331486 |
| 18 | negative regulation of transcription by competitive promoter binding (GO:0010944) | 4.78488236 |
| 19 | protein targeting to ER (GO:0045047) | 4.69416031 |
| 20 | positive regulation of B cell differentiation (GO:0045579) | 4.67223055 |
| 21 | cotranslational protein targeting to membrane (GO:0006613) | 4.66168532 |
| 22 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 4.54913891 |
| 23 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 4.50541847 |
| 24 | viral life cycle (GO:0019058) | 4.46126999 |
| 25 | cellular protein complex disassembly (GO:0043624) | 4.41596923 |
| 26 | kynurenine metabolic process (GO:0070189) | 4.35158025 |
| 27 | protein localization to endoplasmic reticulum (GO:0070972) | 4.33786294 |
| 28 | negative regulation of viral entry into host cell (GO:0046597) | 4.25428748 |
| 29 | DNA duplex unwinding (GO:0032508) | 4.19241946 |
| 30 | DNA geometric change (GO:0032392) | 4.18586835 |
| 31 | DNA strand elongation involved in DNA replication (GO:0006271) | 4.17100622 |
| 32 | mitochondrial RNA metabolic process (GO:0000959) | 4.11180001 |
| 33 | citrulline biosynthetic process (GO:0019240) | 4.07424015 |
| 34 | negative regulation of mast cell activation (GO:0033004) | 4.04909139 |
| 35 | DNA strand elongation (GO:0022616) | 4.03887513 |
| 36 | tryptophan metabolic process (GO:0006568) | 4.01110688 |
| 37 | protein complex disassembly (GO:0043241) | 4.00740273 |
| 38 | translational initiation (GO:0006413) | 3.96562775 |
| 39 | B cell receptor signaling pathway (GO:0050853) | 3.87902566 |
| 40 | cellular hyperosmotic response (GO:0071474) | 3.84021332 |
| 41 | pentose-phosphate shunt (GO:0006098) | 3.82273342 |
| 42 | maturation of SSU-rRNA (GO:0030490) | 3.80437482 |
| 43 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.79802760 |
| 44 | secretory granule organization (GO:0033363) | 3.79158979 |
| 45 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.77675815 |
| 46 | indolalkylamine metabolic process (GO:0006586) | 3.77352887 |
| 47 | ribosomal large subunit biogenesis (GO:0042273) | 3.69500114 |
| 48 | V(D)J recombination (GO:0033151) | 3.69267938 |
| 49 | translesion synthesis (GO:0019985) | 3.69167092 |
| 50 | negative regulation of epidermis development (GO:0045683) | 3.68631929 |
| 51 | negative regulation of interleukin-12 production (GO:0032695) | 3.68042814 |
| 52 | positive regulation of defense response to virus by host (GO:0002230) | 3.67716403 |
| 53 | DNA replication initiation (GO:0006270) | 3.65076427 |
| 54 | protein localization to chromosome, centromeric region (GO:0071459) | 3.64998210 |
| 55 | macromolecular complex disassembly (GO:0032984) | 3.60922423 |
| 56 | DNA deamination (GO:0045006) | 3.57486144 |
| 57 | positive regulation of heat generation (GO:0031652) | 3.56247638 |
| 58 | regulation of hydrogen peroxide metabolic process (GO:0010310) | 3.55753953 |
| 59 | regulation of viral entry into host cell (GO:0046596) | 3.47667079 |
| 60 | blood coagulation, intrinsic pathway (GO:0007597) | 3.47597143 |
| 61 | negative regulation of viral transcription (GO:0032897) | 3.47308626 |
| 62 | Peyers patch development (GO:0048541) | 3.42386524 |
| 63 | mucosal-associated lymphoid tissue development (GO:0048537) | 3.42386524 |
| 64 | cellular biogenic amine catabolic process (GO:0042402) | 3.42056633 |
| 65 | amine catabolic process (GO:0009310) | 3.42056633 |
| 66 | L-fucose catabolic process (GO:0042355) | 3.41680244 |
| 67 | fucose catabolic process (GO:0019317) | 3.41680244 |
| 68 | L-fucose metabolic process (GO:0042354) | 3.41680244 |
| 69 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.41509202 |
| 70 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.39342885 |
| 71 | mitotic recombination (GO:0006312) | 3.35215288 |
| 72 | alternative mRNA splicing, via spliceosome (GO:0000380) | 3.34877712 |
| 73 | regulation of B cell differentiation (GO:0045577) | 3.29665434 |
| 74 | positive regulation of natural killer cell activation (GO:0032816) | 3.29180472 |
| 75 | mRNA catabolic process (GO:0006402) | 3.29048566 |
| 76 | regulation of heat generation (GO:0031650) | 3.23616514 |
| 77 | positive regulation of prostaglandin secretion (GO:0032308) | 3.19668473 |
| 78 | immunoglobulin mediated immune response (GO:0016064) | 3.17189672 |
| 79 | NADPH regeneration (GO:0006740) | 3.17051759 |
| 80 | mitotic metaphase plate congression (GO:0007080) | 3.16803509 |
| 81 | protein targeting to membrane (GO:0006612) | 3.16032959 |
| 82 | aromatic amino acid family catabolic process (GO:0009074) | 3.15938547 |
| 83 | RNA catabolic process (GO:0006401) | 3.12328872 |
| 84 | negative regulation of phagocytosis (GO:0050765) | 3.12264833 |
| 85 | intra-S DNA damage checkpoint (GO:0031573) | 3.11948899 |
| 86 | defense response to fungus (GO:0050832) | 3.11220441 |
| 87 | nuclear-transcribed mRNA catabolic process (GO:0000956) | 3.11010022 |
| 88 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.10927567 |
| 89 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.10927567 |
| 90 | heart trabecula formation (GO:0060347) | 3.09660886 |
| 91 | positive regulation of granulocyte differentiation (GO:0030854) | 3.09233794 |
| 92 | proline metabolic process (GO:0006560) | 3.08412759 |
| 93 | NAD biosynthetic process (GO:0009435) | 3.06128703 |
| 94 | negative regulation of calcium ion transport into cytosol (GO:0010523) | 3.03087836 |
| 95 | metaphase plate congression (GO:0051310) | 3.02730411 |
| 96 | anterograde synaptic vesicle transport (GO:0048490) | 3.02710613 |
| 97 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.00919739 |
| 98 | regulation of viral release from host cell (GO:1902186) | 3.00249485 |
| 99 | germ cell migration (GO:0008354) | 2.99868941 |
| 100 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 2.98254588 |
| 101 | negative regulation of telomere maintenance (GO:0032205) | 2.97722210 |
| 102 | antibacterial humoral response (GO:0019731) | 2.95778707 |
| 103 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.95592352 |
| 104 | regulation of exit from mitosis (GO:0007096) | 2.93730597 |
| 105 | definitive hemopoiesis (GO:0060216) | 2.93610404 |
| 106 | positive regulation of histone deacetylation (GO:0031065) | 2.91113403 |
| 107 | defense response to protozoan (GO:0042832) | 2.90846698 |
| 108 | telomere maintenance via recombination (GO:0000722) | 2.90376959 |
| 109 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 2.89851126 |
| 110 | cellular response to ATP (GO:0071318) | 2.89608329 |
| 111 | developmental pigmentation (GO:0048066) | 2.88886993 |
| 112 | DNA replication checkpoint (GO:0000076) | 2.88231231 |
| 113 | heparin biosynthetic process (GO:0030210) | 2.86642445 |
| 114 | heparin metabolic process (GO:0030202) | 2.86642445 |
| 115 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.86492112 |
| 116 | response to protozoan (GO:0001562) | 2.86406845 |
| 117 | interferon-gamma production (GO:0032609) | 2.85792440 |
| 118 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.83850780 |
| 119 | response to interferon-beta (GO:0035456) | 2.82997902 |
| 120 | antimicrobial humoral response (GO:0019730) | 2.82872895 |
| 121 | barbed-end actin filament capping (GO:0051016) | 2.81219796 |
| 122 | negative regulation of RNA splicing (GO:0033119) | 2.79291144 |
| 123 | positive regulation of DNA biosynthetic process (GO:2000573) | 2.77453887 |
| 124 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.77150921 |
| 125 | intracellular pH reduction (GO:0051452) | 2.76305500 |
| 126 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.75792575 |
| 127 | telomere maintenance via telomere lengthening (GO:0010833) | 2.75493252 |
| 128 | cell wall macromolecule catabolic process (GO:0016998) | 2.74248600 |
| 129 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.71775844 |
| 130 | phagosome maturation (GO:0090382) | 2.71361773 |
| 131 | arginine catabolic process (GO:0006527) | 2.71216223 |
| 132 | cellular response to exogenous dsRNA (GO:0071360) | 2.70106216 |
| 133 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.68724114 |
| 134 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 2.67779896 |
| 135 | negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642) | 2.67033365 |
| 136 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.64827900 |
| 137 | response to type I interferon (GO:0034340) | 2.64205184 |
| 138 | regulation of defense response to virus by host (GO:0050691) | 2.63118463 |
| 139 | cellular ketone body metabolic process (GO:0046950) | 2.62996762 |
| 140 | cellular response to type I interferon (GO:0071357) | 2.61662042 |
| 141 | type I interferon signaling pathway (GO:0060337) | 2.61662042 |
| 142 | positive regulation of antigen processing and presentation (GO:0002579) | 2.61258344 |
| 143 | negative regulation of macrophage differentiation (GO:0045650) | 2.60891833 |
| 144 | indole-containing compound metabolic process (GO:0042430) | 2.60016301 |
| 145 | protein K11-linked deubiquitination (GO:0035871) | 2.59610272 |
| 146 | regulation of memory T cell differentiation (GO:0043380) | 2.59177601 |
| 147 | cAMP catabolic process (GO:0006198) | 2.57631208 |
| 148 | regulation of prostaglandin secretion (GO:0032306) | 2.53963237 |
| 149 | cellular response to interferon-beta (GO:0035458) | 2.53636680 |
| 150 | N-acetylneuraminate metabolic process (GO:0006054) | 2.53405882 |
| 151 | pyridine nucleotide biosynthetic process (GO:0019363) | 2.50893023 |
| 152 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 2.50893023 |
| 153 | amino sugar catabolic process (GO:0046348) | 2.48518601 |
| 154 | regulation of interferon-alpha production (GO:0032647) | 2.47589476 |
| 155 | response to pheromone (GO:0019236) | 2.46112598 |
| 156 | behavioral response to nicotine (GO:0035095) | 2.43999595 |
| 157 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.43832988 |
| 158 | negative regulation of interleukin-1 beta production (GO:0032691) | 2.43151681 |
| 159 | regulation of cytokine secretion involved in immune response (GO:0002739) | 2.43131636 |
| 160 | glycerophospholipid catabolic process (GO:0046475) | 2.43074473 |
| 161 | regulation of MHC class II biosynthetic process (GO:0045346) | 2.42882306 |
| 162 | cell wall macromolecule metabolic process (GO:0044036) | 2.41056704 |
| 163 | lytic vacuole organization (GO:0080171) | 2.40990348 |
| 164 | lysosome organization (GO:0007040) | 2.40990348 |
| 165 | pH reduction (GO:0045851) | 2.40490904 |
| 166 | eosinophil chemotaxis (GO:0048245) | 2.40291014 |
| 167 | ketone body metabolic process (GO:1902224) | 2.36832745 |
| 168 | adaptation of signaling pathway (GO:0023058) | 2.36729121 |
| 169 | regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640) | 2.36480152 |
| 170 | negative regulation of lipid storage (GO:0010888) | 2.36296797 |
| 171 | cellular response to ethanol (GO:0071361) | 2.36182529 |
| 172 | regulation of nuclear cell cycle DNA replication (GO:0033262) | 2.34575619 |
| 173 | regulation of chronic inflammatory response (GO:0002676) | 2.34503550 |
| 174 | regulation of antigen processing and presentation (GO:0002577) | 2.34246964 |
| 175 | vitamin biosynthetic process (GO:0009110) | 2.33488943 |
| 176 | sphingoid metabolic process (GO:0046519) | 2.33425907 |
| 177 | arginine metabolic process (GO:0006525) | 2.32969994 |
| 178 | negative regulation of granulocyte differentiation (GO:0030853) | 2.32930714 |
| 179 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 2.31799058 |
| 180 | regulation of fever generation (GO:0031620) | 2.29830213 |
| 181 | benzene-containing compound metabolic process (GO:0042537) | 2.29693496 |
| 182 | cyclic nucleotide catabolic process (GO:0009214) | 2.29071114 |
| 183 | regulation of interleukin-12 production (GO:0032655) | 2.27953433 |
| 184 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 2.26982221 |
| 185 | positive regulation of fatty acid transport (GO:2000193) | 2.25549452 |
| 186 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.24413669 |
| 187 | T-helper 1 type immune response (GO:0042088) | 2.23153930 |
| 188 | regulation of MHC class I biosynthetic process (GO:0045343) | 2.22964298 |
| 189 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 2.22607236 |
| 190 | cytokine biosynthetic process (GO:0042089) | 2.21921627 |
| 191 | regulation of mast cell activation (GO:0033003) | 2.21364341 |
| 192 | B cell mediated immunity (GO:0019724) | 2.21224980 |
| 193 | detection of light stimulus involved in visual perception (GO:0050908) | 2.20998019 |
| 194 | detection of light stimulus involved in sensory perception (GO:0050962) | 2.20998019 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 9.09355709 |
| 2 | ZNF274_21170338_ChIP-Seq_K562_Hela | 3.59110402 |
| 3 | MYC_22102868_ChIP-Seq_BL_Human | 3.55039654 |
| 4 | VDR_21846776_ChIP-Seq_THP-1_Human | 3.43467560 |
| 5 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.22121989 |
| 6 | SCL_19346495_ChIP-Seq_HPC-7_Human | 3.04491999 |
| 7 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.95034218 |
| 8 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.87121866 |
| 9 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.76880794 |
| 10 | VDR_22108803_ChIP-Seq_LS180_Human | 2.73352110 |
| 11 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.71383181 |
| 12 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.69712131 |
| 13 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.56021360 |
| 14 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.54934180 |
| 15 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.54025036 |
| 16 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.46594010 |
| 17 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.44681210 |
| 18 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.39809383 |
| 19 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.33125977 |
| 20 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.24603845 |
| 21 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.20484011 |
| 22 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.18700143 |
| 23 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.18212024 |
| 24 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.18141186 |
| 25 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.15791888 |
| 26 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.13140913 |
| 27 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.13136168 |
| 28 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.01108823 |
| 29 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.99990265 |
| 30 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.99834229 |
| 31 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.96019405 |
| 32 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.95334172 |
| 33 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.93961994 |
| 34 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.92512462 |
| 35 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.90663642 |
| 36 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.89454327 |
| 37 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.83888540 |
| 38 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.79025057 |
| 39 | UTX_26944678_Chip-Seq_JUKART_Human | 1.70190827 |
| 40 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.70111707 |
| 41 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.69515134 |
| 42 | * MYB_26560356_Chip-Seq_TH2_Human | 1.69429758 |
| 43 | GATA1_22025678_ChIP-Seq_K562_Human | 1.68170127 |
| 44 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.67036741 |
| 45 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.65395377 |
| 46 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.63488246 |
| 47 | P300_19829295_ChIP-Seq_ESCs_Human | 1.61601242 |
| 48 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.61091030 |
| 49 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.59857628 |
| 50 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.58929376 |
| 51 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.57762231 |
| 52 | MAF_26560356_Chip-Seq_TH1_Human | 1.57050015 |
| 53 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.56994929 |
| 54 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.56160353 |
| 55 | GATA3_26560356_Chip-Seq_TH2_Human | 1.55206927 |
| 56 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.55134540 |
| 57 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.55078827 |
| 58 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.54513912 |
| 59 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.53582371 |
| 60 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.53262215 |
| 61 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.53191985 |
| 62 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.53095558 |
| 63 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.51869487 |
| 64 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.51457649 |
| 65 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.51343273 |
| 66 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.50713394 |
| 67 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.48657046 |
| 68 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.48050740 |
| 69 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.48040377 |
| 70 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.47941788 |
| 71 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.47622878 |
| 72 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.47257819 |
| 73 | * UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.46659150 |
| 74 | * CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.46393624 |
| 75 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.45854407 |
| 76 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.44333590 |
| 77 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.44105381 |
| 78 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.42224131 |
| 79 | MYB_26560356_Chip-Seq_TH1_Human | 1.41632801 |
| 80 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.41136858 |
| 81 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.41022984 |
| 82 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.40923032 |
| 83 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.40439103 |
| 84 | AR_25329375_ChIP-Seq_VCAP_Human | 1.39536257 |
| 85 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.39461759 |
| 86 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.39461759 |
| 87 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.37877801 |
| 88 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.37268235 |
| 89 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.37268235 |
| 90 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.36216791 |
| 91 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.35997545 |
| 92 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.33473344 |
| 93 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.32302691 |
| 94 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.32212692 |
| 95 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.31542674 |
| 96 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.30968999 |
| 97 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.29927190 |
| 98 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.28647603 |
| 99 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.28647603 |
| 100 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.28332016 |
| 101 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.27480435 |
| 102 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.26845736 |
| 103 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.26298486 |
| 104 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.25023610 |
| 105 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.23641091 |
| 106 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.23387614 |
| 107 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.23088689 |
| 108 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.23042724 |
| 109 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.21466754 |
| 110 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.21318087 |
| 111 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.21186567 |
| 112 | * SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.19262199 |
| 113 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.18600557 |
| 114 | EWS_26573619_Chip-Seq_HEK293_Human | 1.17547579 |
| 115 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.17343879 |
| 116 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.16834318 |
| 117 | AR_20517297_ChIP-Seq_VCAP_Human | 1.14664298 |
| 118 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.14024029 |
| 119 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.13546383 |
| 120 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.13520151 |
| 121 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.13092096 |
| 122 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.11802527 |
| 123 | SMRT_27268052_Chip-Seq_Bcells_Human | 1.11576473 |
| 124 | TCF4_23295773_ChIP-Seq_U87_Human | 1.11203654 |
| 125 | * TCF4_22108803_ChIP-Seq_LS180_Human | 1.10682394 |
| 126 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.10506749 |
| 127 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.09929541 |
| 128 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.09325398 |
| 129 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.09322205 |
| 130 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.09297670 |
| 131 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.09260245 |
| 132 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.08786107 |
| 133 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.08661809 |
| 134 | MAF_26560356_Chip-Seq_TH2_Human | 1.08583543 |
| 135 | SPI1_23127762_ChIP-Seq_K562_Human | 1.08436138 |
| 136 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.07981052 |
| 137 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.07769380 |
| 138 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.07329360 |
| 139 | TAF2_19829295_ChIP-Seq_ESCs_Human | 1.06936180 |
| 140 | * SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.05714266 |
| 141 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.04837885 |
| 142 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.03855290 |
| 143 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.03702651 |
| 144 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.03279565 |
| 145 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.03137911 |
| 146 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.02899373 |
| 147 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.01992168 |
| 148 | MYC_19829295_ChIP-Seq_ESCs_Human | 1.00362226 |
| 149 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.00318083 |
| 150 | FUS_26573619_Chip-Seq_HEK293_Human | 0.99630556 |
| 151 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.99543951 |
| 152 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.99065081 |
| 153 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 0.99010514 |
| 154 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.98394614 |
| 155 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.98178294 |
| 156 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.98178294 |
| 157 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.98141043 |
| 158 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.97958138 |
| 159 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.97728085 |
| 160 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.96932634 |
| 161 | * CJUN_26792858_Chip-Seq_BT549_Human | 0.96823802 |
| 162 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.96309288 |
| 163 | MYC_18940864_ChIP-ChIP_HL60_Human | 0.95272171 |
| 164 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.95143456 |
| 165 | DCP1A_22483619_ChIP-Seq_HELA_Human | 0.94575291 |
| 166 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 0.94317510 |
| 167 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.93421337 |
| 168 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 0.93347865 |
| 169 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.93262380 |
| 170 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.93002906 |
| 171 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.92934114 |
| 172 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.91930853 |
| 173 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.91527964 |
| 174 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.90985169 |
| 175 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 0.88595520 |
| 176 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.88189075 |
| 177 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.87712749 |
| 178 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 0.87445305 |
| 179 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.87127066 |
| 180 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.86621679 |
| 181 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.86615334 |
| 182 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 0.86246613 |
| 183 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.85661984 |
| 184 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.84845632 |
| 185 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.84149570 |
| 186 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.82511374 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0009840_abnormal_foam_cell | 7.21132904 |
| 2 | MP0002102_abnormal_ear_morphology | 4.28754543 |
| 3 | MP0005174_abnormal_tail_pigmentation | 4.00835522 |
| 4 | MP0003195_calcinosis | 3.42226010 |
| 5 | MP0003172_abnormal_lysosome_physiology | 2.99985218 |
| 6 | MP0003646_muscle_fatigue | 2.92725953 |
| 7 | MP0000015_abnormal_ear_pigmentation | 2.84707792 |
| 8 | MP0005167_abnormal_blood-brain_barrier | 2.83601688 |
| 9 | MP0002396_abnormal_hematopoietic_system | 2.80597704 |
| 10 | MP0003724_increased_susceptibility_to | 2.60772358 |
| 11 | MP0009764_decreased_sensitivity_to | 2.47140255 |
| 12 | MP0009278_abnormal_bone_marrow | 2.43223506 |
| 13 | MP0002837_dystrophic_cardiac_calcinosis | 2.34047891 |
| 14 | MP0004808_abnormal_hematopoietic_stem | 2.28906858 |
| 15 | MP0010094_abnormal_chromosome_stability | 2.23907856 |
| 16 | MP0000685_abnormal_immune_system | 2.22608320 |
| 17 | MP0000465_gastrointestinal_hemorrhage | 2.19253268 |
| 18 | MP0005397_hematopoietic_system_phenotyp | 2.17947512 |
| 19 | MP0001545_abnormal_hematopoietic_system | 2.17947512 |
| 20 | MP0003300_gastrointestinal_ulcer | 2.16506527 |
| 21 | MP0000462_abnormal_digestive_system | 2.08813552 |
| 22 | MP0002138_abnormal_hepatobiliary_system | 2.08637983 |
| 23 | MP0001501_abnormal_sleep_pattern | 2.07689070 |
| 24 | MP0010352_gastrointestinal_tract_polyps | 2.02051287 |
| 25 | MP0002139_abnormal_hepatobiliary_system | 1.97393458 |
| 26 | MP0005075_abnormal_melanosome_morpholog | 1.96714299 |
| 27 | MP0005464_abnormal_platelet_physiology | 1.95775563 |
| 28 | MP0003763_abnormal_thymus_physiology | 1.91793768 |
| 29 | MP0002166_altered_tumor_susceptibility | 1.91426009 |
| 30 | MP0004381_abnormal_hair_follicle | 1.86925186 |
| 31 | MP0003656_abnormal_erythrocyte_physiolo | 1.84868556 |
| 32 | MP0001348_abnormal_lacrimal_gland | 1.79557971 |
| 33 | MP0003566_abnormal_cell_adhesion | 1.78686525 |
| 34 | MP0004043_abnormal_pH_regulation | 1.77414470 |
| 35 | MP0005058_abnormal_lysosome_morphology | 1.75704821 |
| 36 | MP0002060_abnormal_skin_morphology | 1.73615454 |
| 37 | MP0002006_tumorigenesis | 1.68972430 |
| 38 | MP0001800_abnormal_humoral_immune | 1.68396395 |
| 39 | MP0002398_abnormal_bone_marrow | 1.67859797 |
| 40 | MP0001835_abnormal_antigen_presentation | 1.67106855 |
| 41 | MP0009379_abnormal_foot_pigmentation | 1.66262227 |
| 42 | MP0008875_abnormal_xenobiotic_pharmacok | 1.65510617 |
| 43 | MP0003191_abnormal_cellular_cholesterol | 1.63302303 |
| 44 | MP0004947_skin_inflammation | 1.61786091 |
| 45 | MP0010386_abnormal_urinary_bladder | 1.60240435 |
| 46 | MP0003283_abnormal_digestive_organ | 1.60214821 |
| 47 | MP0003303_peritoneal_inflammation | 1.59755879 |
| 48 | MP0000703_abnormal_thymus_morphology | 1.59662755 |
| 49 | MP0002254_reproductive_system_inflammat | 1.58969214 |
| 50 | MP0002722_abnormal_immune_system | 1.55787246 |
| 51 | MP0005645_abnormal_hypothalamus_physiol | 1.55781849 |
| 52 | MP0002452_abnormal_antigen_presenting | 1.54866360 |
| 53 | MP0005000_abnormal_immune_tolerance | 1.51018151 |
| 54 | MP0001873_stomach_inflammation | 1.49710188 |
| 55 | MP0009046_muscle_twitch | 1.49409166 |
| 56 | MP0002095_abnormal_skin_pigmentation | 1.49404871 |
| 57 | MP0003806_abnormal_nucleotide_metabolis | 1.46508237 |
| 58 | MP0002405_respiratory_system_inflammati | 1.45762217 |
| 59 | MP0003950_abnormal_plasma_membrane | 1.44639387 |
| 60 | MP0005387_immune_system_phenotype | 1.44545368 |
| 61 | MP0001790_abnormal_immune_system | 1.44545368 |
| 62 | MP0000689_abnormal_spleen_morphology | 1.42694047 |
| 63 | MP0005310_abnormal_salivary_gland | 1.40748570 |
| 64 | MP0001853_heart_inflammation | 1.40179242 |
| 65 | MP0001243_abnormal_dermal_layer | 1.40003980 |
| 66 | MP0008057_abnormal_DNA_replication | 1.38756399 |
| 67 | MP0003075_altered_response_to | 1.38577039 |
| 68 | MP0000490_abnormal_crypts_of | 1.37402703 |
| 69 | MP0000604_amyloidosis | 1.35839646 |
| 70 | MP0002420_abnormal_adaptive_immunity | 1.35708809 |
| 71 | MP0000716_abnormal_immune_system | 1.34163143 |
| 72 | MP0006054_spinal_hemorrhage | 1.33882101 |
| 73 | MP0004510_myositis | 1.33785373 |
| 74 | MP0001819_abnormal_immune_cell | 1.32810980 |
| 75 | MP0002723_abnormal_immune_serum | 1.30741159 |
| 76 | MP0001764_abnormal_homeostasis | 1.30557819 |
| 77 | MP0006082_CNS_inflammation | 1.24733115 |
| 78 | MP0003436_decreased_susceptibility_to | 1.24199213 |
| 79 | MP0002933_joint_inflammation | 1.23939181 |
| 80 | MP0002429_abnormal_blood_cell | 1.23470570 |
| 81 | MP0001986_abnormal_taste_sensitivity | 1.22329791 |
| 82 | MP0000343_altered_response_to | 1.21041697 |
| 83 | MP0010155_abnormal_intestine_physiology | 1.20328600 |
| 84 | MP0008469_abnormal_protein_level | 1.20276056 |
| 85 | MP0008995_early_reproductive_senescence | 1.17576572 |
| 86 | MP0002234_abnormal_pharynx_morphology | 1.17124551 |
| 87 | MP0003045_fibrosis | 1.16750830 |
| 88 | MP0005551_abnormal_eye_electrophysiolog | 1.15959062 |
| 89 | MP0000377_abnormal_hair_follicle | 1.13842516 |
| 90 | MP0005671_abnormal_response_to | 1.13810675 |
| 91 | MP0005025_abnormal_response_to | 1.12289726 |
| 92 | MP0001919_abnormal_reproductive_system | 1.11758100 |
| 93 | MP0009333_abnormal_splenocyte_physiolog | 1.10955701 |
| 94 | MP0008877_abnormal_DNA_methylation | 1.10721518 |
| 95 | MP0005381_digestive/alimentary_phenotyp | 1.10586318 |
| 96 | MP0003693_abnormal_embryo_hatching | 1.08019132 |
| 97 | MP0003705_abnormal_hypodermis_morpholog | 1.06266086 |
| 98 | MP0003077_abnormal_cell_cycle | 1.06062847 |
| 99 | MP0009780_abnormal_chondrocyte_physiolo | 1.05286163 |
| 100 | MP0008007_abnormal_cellular_replicative | 1.04872916 |
| 101 | MP0002876_abnormal_thyroid_physiology | 1.03787560 |
| 102 | MP0009785_altered_susceptibility_to | 1.03650529 |
| 103 | MP0008770_decreased_survivor_rate | 1.02105630 |
| 104 | MP0010307_abnormal_tumor_latency | 1.01258328 |
| 105 | MP0003279_aneurysm | 1.01225827 |
| 106 | MP0001663_abnormal_digestive_system | 1.00820881 |
| 107 | MP0002693_abnormal_pancreas_physiology | 0.99374792 |
| 108 | MP0005360_urolithiasis | 0.97463311 |
| 109 | MP0005253_abnormal_eye_physiology | 0.97362962 |
| 110 | MP0005410_abnormal_fertilization | 0.97156496 |
| 111 | MP0005647_abnormal_sex_gland | 0.96799422 |
| 112 | MP0000858_altered_metastatic_potential | 0.95565694 |
| 113 | MP0000750_abnormal_muscle_regeneration | 0.95553218 |
| 114 | MP0005367_renal/urinary_system_phenotyp | 0.94188921 |
| 115 | MP0000516_abnormal_urinary_system | 0.94188921 |
| 116 | MP0002419_abnormal_innate_immunity | 0.93546815 |
| 117 | MP0006072_abnormal_retinal_apoptosis | 0.93218343 |
| 118 | MP0004883_abnormal_blood_vessel | 0.91576409 |
| 119 | MP0003111_abnormal_nucleus_morphology | 0.91434185 |
| 120 | MP0002019_abnormal_tumor_incidence | 0.90792833 |
| 121 | MP0005646_abnormal_pituitary_gland | 0.90692355 |
| 122 | MP0008438_abnormal_cutaneous_collagen | 0.88837195 |
| 123 | MP0008872_abnormal_physiological_respon | 0.86414162 |
| 124 | MP0002269_muscular_atrophy | 0.85973075 |
| 125 | MP0002332_abnormal_exercise_endurance | 0.85050543 |
| 126 | MP0010234_abnormal_vibrissa_follicle | 0.83982530 |
| 127 | MP0003091_abnormal_cell_migration | 0.83927771 |
| 128 | MP0002148_abnormal_hypersensitivity_rea | 0.83649173 |
| 129 | MP0002970_abnormal_white_adipose | 0.82795129 |
| 130 | MP0002277_abnormal_respiratory_mucosa | 0.81701274 |
| 131 | MP0003718_maternal_effect | 0.81176899 |
| 132 | MP0005365_abnormal_bile_salt | 0.80459113 |
| 133 | MP0000230_abnormal_systemic_arterial | 0.79777493 |
| 134 | MP0000647_abnormal_sebaceous_gland | 0.79612505 |
| 135 | MP0003633_abnormal_nervous_system | 0.79091392 |
| 136 | MP0003938_abnormal_ear_development | 0.79005729 |
| 137 | MP0000569_abnormal_digit_pigmentation | 0.77376776 |
| 138 | MP0000371_diluted_coat_color | 0.77253456 |
| 139 | MP0000313_abnormal_cell_death | 0.76194044 |
| 140 | MP0005595_abnormal_vascular_smooth | 0.76105257 |
| 141 | MP0009745_abnormal_behavioral_response | 0.76092673 |
| 142 | MP0002998_abnormal_bone_remodeling | 0.75506686 |
| 143 | MP0003786_premature_aging | 0.75253296 |
| 144 | MP0000477_abnormal_intestine_morphology | 0.74961964 |
| 145 | MP0001968_abnormal_touch/_nociception | 0.74451436 |
| 146 | MP0001970_abnormal_pain_threshold | 0.73161285 |
| 147 | MP0001533_abnormal_skeleton_physiology | 0.72954131 |
| 148 | MP0005084_abnormal_gallbladder_morpholo | 0.72916291 |
| 149 | MP0001845_abnormal_inflammatory_respons | 0.72514811 |
| 150 | MP0002736_abnormal_nociception_after | 0.72459122 |
| 151 | MP0004272_abnormal_basement_membrane | 0.72334430 |
| 152 | MP0000470_abnormal_stomach_morphology | 0.71600723 |
| 153 | MP0000733_abnormal_muscle_development | 0.71409371 |
| 154 | MP0001849_ear_inflammation | 0.70942902 |
| 155 | MP0005166_decreased_susceptibility_to | 0.70658997 |
| 156 | MP0000383_abnormal_hair_follicle | 0.69938691 |
| 157 | MP0001542_abnormal_bone_strength | 0.69738164 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Reticulocytopenia (HP:0001896) | 5.59152622 |
| 2 | Increased mean platelet volume (HP:0011877) | 5.25389513 |
| 3 | Abnormal platelet volume (HP:0011876) | 5.24031004 |
| 4 | Albinism (HP:0001022) | 4.82111397 |
| 5 | Autoimmune thrombocytopenia (HP:0001973) | 4.76905985 |
| 6 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.66125286 |
| 7 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.66125286 |
| 8 | Abnormality of glycolipid metabolism (HP:0010969) | 4.66125286 |
| 9 | Prolonged bleeding time (HP:0003010) | 4.50411183 |
| 10 | Purpura (HP:0000979) | 4.01650183 |
| 11 | Cellulitis (HP:0100658) | 4.01297308 |
| 12 | B lymphocytopenia (HP:0010976) | 3.97082165 |
| 13 | Abnormality of B cell number (HP:0010975) | 3.97082165 |
| 14 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.87566048 |
| 15 | Chronic otitis media (HP:0000389) | 3.84173443 |
| 16 | Increased cerebral lipofuscin (HP:0011813) | 3.83931748 |
| 17 | Stomatitis (HP:0010280) | 3.80159461 |
| 18 | Panhypogammaglobulinemia (HP:0003139) | 3.74021601 |
| 19 | Vacuolated lymphocytes (HP:0001922) | 3.68939580 |
| 20 | Menorrhagia (HP:0000132) | 3.63734111 |
| 21 | Recurrent viral infections (HP:0004429) | 3.58497635 |
| 22 | Hematochezia (HP:0002573) | 3.46543004 |
| 23 | Hypoproteinemia (HP:0003075) | 3.46040956 |
| 24 | Papilledema (HP:0001085) | 3.44136331 |
| 25 | Muscle fiber atrophy (HP:0100295) | 3.43630344 |
| 26 | Dysostosis multiplex (HP:0000943) | 3.41087735 |
| 27 | Abnormality of cells of the erythroid lineage (HP:0012130) | 3.40816940 |
| 28 | Thyroiditis (HP:0100646) | 3.37278985 |
| 29 | Pancreatic cysts (HP:0001737) | 3.32355119 |
| 30 | Abnormal number of erythroid precursors (HP:0012131) | 3.19927998 |
| 31 | Pallor (HP:0000980) | 3.16061764 |
| 32 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.13053337 |
| 33 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.13053337 |
| 34 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.13053337 |
| 35 | T lymphocytopenia (HP:0005403) | 3.12554667 |
| 36 | Petechiae (HP:0000967) | 3.12252556 |
| 37 | Abnormal platelet function (HP:0011869) | 3.06461349 |
| 38 | Impaired platelet aggregation (HP:0003540) | 3.06461349 |
| 39 | Congenital stationary night blindness (HP:0007642) | 3.03534165 |
| 40 | Increased density of long bones (HP:0006392) | 2.97811315 |
| 41 | Retrobulbar optic neuritis (HP:0100654) | 2.92086900 |
| 42 | Optic neuritis (HP:0100653) | 2.92086900 |
| 43 | Hyperventilation (HP:0002883) | 2.87980798 |
| 44 | Abnormality of T cell number (HP:0011839) | 2.84235720 |
| 45 | Clumsiness (HP:0002312) | 2.81962544 |
| 46 | Ankle contracture (HP:0006466) | 2.80927144 |
| 47 | Polydipsia (HP:0001959) | 2.79868500 |
| 48 | Abnormal drinking behavior (HP:0030082) | 2.79868500 |
| 49 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.79033786 |
| 50 | Mucopolysacchariduria (HP:0008155) | 2.79033786 |
| 51 | Progressive neurologic deterioration (HP:0002344) | 2.76469956 |
| 52 | Colon cancer (HP:0003003) | 2.74388393 |
| 53 | Severe short stature (HP:0003510) | 2.73613935 |
| 54 | Type 2 muscle fiber atrophy (HP:0003554) | 2.68180641 |
| 55 | Hypoplasia of the thymus (HP:0000778) | 2.66985893 |
| 56 | Abolished electroretinogram (ERG) (HP:0000550) | 2.65561240 |
| 57 | Abnormality of the renal cortex (HP:0011035) | 2.64995244 |
| 58 | Pancreatic fibrosis (HP:0100732) | 2.64692366 |
| 59 | Stomach cancer (HP:0012126) | 2.64277223 |
| 60 | Abnormality of midbrain morphology (HP:0002418) | 2.61588613 |
| 61 | Molar tooth sign on MRI (HP:0002419) | 2.61588613 |
| 62 | Orchitis (HP:0100796) | 2.61246166 |
| 63 | Severe visual impairment (HP:0001141) | 2.60404332 |
| 64 | Methylmalonic aciduria (HP:0012120) | 2.57928387 |
| 65 | Agammaglobulinemia (HP:0004432) | 2.56486054 |
| 66 | Premature rupture of membranes (HP:0001788) | 2.56231504 |
| 67 | Myositis (HP:0100614) | 2.54108538 |
| 68 | Recurrent fungal infections (HP:0002841) | 2.52392248 |
| 69 | Prostate neoplasm (HP:0100787) | 2.49119120 |
| 70 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.48679422 |
| 71 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.46437828 |
| 72 | Protrusio acetabuli (HP:0003179) | 2.45856941 |
| 73 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.44568538 |
| 74 | Poor head control (HP:0002421) | 2.44036525 |
| 75 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.42855331 |
| 76 | Ulnar bowing (HP:0003031) | 2.42423345 |
| 77 | Osteomyelitis (HP:0002754) | 2.41889692 |
| 78 | Attenuation of retinal blood vessels (HP:0007843) | 2.40326056 |
| 79 | Abnormality of reticulocytes (HP:0004312) | 2.37058377 |
| 80 | Thrombocytosis (HP:0001894) | 2.34955461 |
| 81 | Ocular albinism (HP:0001107) | 2.30737985 |
| 82 | IgM deficiency (HP:0002850) | 2.30590851 |
| 83 | Wormian bones (HP:0002645) | 2.30581397 |
| 84 | Bowing of the arm (HP:0006488) | 2.28893805 |
| 85 | Bowed forearm bones (HP:0003956) | 2.28893805 |
| 86 | Macrocytic anemia (HP:0001972) | 2.28549213 |
| 87 | Verrucae (HP:0200043) | 2.27642636 |
| 88 | Papilloma (HP:0012740) | 2.27642636 |
| 89 | Disproportionate short-trunk short stature (HP:0003521) | 2.24873052 |
| 90 | Progressive inability to walk (HP:0002505) | 2.24670059 |
| 91 | Congenital sensorineural hearing impairment (HP:0008527) | 2.23337903 |
| 92 | Severe combined immunodeficiency (HP:0004430) | 2.21845200 |
| 93 | Epistaxis (HP:0000421) | 2.21317680 |
| 94 | Abnormality of macrophages (HP:0004311) | 2.20592613 |
| 95 | True hermaphroditism (HP:0010459) | 2.20223619 |
| 96 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 2.19109597 |
| 97 | Combined immunodeficiency (HP:0005387) | 2.17782020 |
| 98 | Atrophic scars (HP:0001075) | 2.17299325 |
| 99 | Asplenia (HP:0001746) | 2.16038955 |
| 100 | Nephronophthisis (HP:0000090) | 2.15752062 |
| 101 | Metaphyseal irregularity (HP:0003025) | 2.15020766 |
| 102 | Tubular atrophy (HP:0000092) | 2.14635383 |
| 103 | Hemoptysis (HP:0002105) | 2.14128115 |
| 104 | 11 pairs of ribs (HP:0000878) | 2.13962696 |
| 105 | Poikiloderma (HP:0001029) | 2.13811431 |
| 106 | Loss of speech (HP:0002371) | 2.13643758 |
| 107 | Mutism (HP:0002300) | 2.12970551 |
| 108 | Fragile skin (HP:0001030) | 2.11831703 |
| 109 | Pulmonary infiltrates (HP:0002113) | 2.08621305 |
| 110 | Interstitial pulmonary disease (HP:0006530) | 2.08106081 |
| 111 | Polyuria (HP:0000103) | 2.08093737 |
| 112 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.07295630 |
| 113 | Abnormality of the intervertebral disk (HP:0005108) | 2.03920396 |
| 114 | Generalized aminoaciduria (HP:0002909) | 2.03304559 |
| 115 | Generalized hypopigmentation (HP:0007513) | 2.02021494 |
| 116 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.01912841 |
| 117 | Abnormality of alanine metabolism (HP:0010916) | 2.01912841 |
| 118 | Hyperalaninemia (HP:0003348) | 2.01912841 |
| 119 | Recurrent bacterial skin infections (HP:0005406) | 2.01525450 |
| 120 | Pili torti (HP:0003777) | 2.01217962 |
| 121 | Bile duct proliferation (HP:0001408) | 2.00657007 |
| 122 | Abnormal biliary tract physiology (HP:0012439) | 2.00657007 |
| 123 | Parakeratosis (HP:0001036) | 2.00373992 |
| 124 | Ketoacidosis (HP:0001993) | 2.00091907 |
| 125 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.99986286 |
| 126 | Abnormality of the renal medulla (HP:0100957) | 1.99234344 |
| 127 | Gaze-evoked nystagmus (HP:0000640) | 1.99005326 |
| 128 | Volvulus (HP:0002580) | 1.98832571 |
| 129 | Methylmalonic acidemia (HP:0002912) | 1.98742206 |
| 130 | Tongue fasciculations (HP:0001308) | 1.98479500 |
| 131 | Rectal prolapse (HP:0002035) | 1.97544464 |
| 132 | Type II lissencephaly (HP:0007260) | 1.97345337 |
| 133 | Basal cell carcinoma (HP:0002671) | 1.96076319 |
| 134 | Chronic hepatic failure (HP:0100626) | 1.96034163 |
| 135 | Keratoconjunctivitis (HP:0001096) | 1.95642491 |
| 136 | Reduced antithrombin III activity (HP:0001976) | 1.95035703 |
| 137 | Abnormality of the prostate (HP:0008775) | 1.94581442 |
| 138 | Congenital hepatic fibrosis (HP:0002612) | 1.93604693 |
| 139 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.93167331 |
| 140 | Gingival bleeding (HP:0000225) | 1.92685315 |
| 141 | Slender long bone (HP:0003100) | 1.92071172 |
| 142 | Radial bowing (HP:0002986) | 1.92017318 |
| 143 | Ileus (HP:0002595) | 1.92005593 |
| 144 | Stridor (HP:0010307) | 1.91061661 |
| 145 | Adactyly (HP:0009776) | 1.90733002 |
| 146 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 1.90665594 |
| 147 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.90646514 |
| 148 | Recurrent cutaneous fungal infections (HP:0011370) | 1.90646514 |
| 149 | Sepsis (HP:0100806) | 1.90638460 |
| 150 | Macular degeneration (HP:0000608) | 1.90540273 |
| 151 | Abnormality of T cells (HP:0002843) | 1.90140123 |
| 152 | Mitral regurgitation (HP:0001653) | 1.90111492 |
| 153 | Osteolytic defects of the hand bones (HP:0009699) | 1.90004704 |
| 154 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.90004704 |
| 155 | Wide cranial sutures (HP:0010537) | 1.89408946 |
| 156 | Bruising susceptibility (HP:0000978) | 1.88708787 |
| 157 | Absent speech (HP:0001344) | 1.88061262 |
| 158 | Mediastinal lymphadenopathy (HP:0100721) | 1.87686532 |
| 159 | Meningitis (HP:0001287) | 1.87678495 |
| 160 | Ketosis (HP:0001946) | 1.86622082 |
| 161 | Hypophosphatemic rickets (HP:0004912) | 1.86385137 |
| 162 | Selective tooth agenesis (HP:0001592) | 1.86385073 |
| 163 | Gastrointestinal inflammation (HP:0004386) | 1.86339919 |
| 164 | Increased corneal curvature (HP:0100692) | 1.85943536 |
| 165 | Keratoconus (HP:0000563) | 1.85943536 |
| 166 | Ankyloglossia (HP:0010296) | 1.85611698 |
| 167 | Lymphoma (HP:0002665) | 1.85508445 |
| 168 | Abnormality of the periventricular white matter (HP:0002518) | 1.84223514 |
| 169 | Tubulointerstitial fibrosis (HP:0005576) | 1.83837226 |
| 170 | Amniotic constriction ring (HP:0009775) | 1.82407933 |
| 171 | Abnormality of placental membranes (HP:0011409) | 1.82407933 |
| 172 | Hyperacusis (HP:0010780) | 1.82400905 |
| 173 | Eosinophilia (HP:0001880) | 1.82243442 |
| 174 | IgG deficiency (HP:0004315) | 1.82098794 |
| 175 | Iris hypopigmentation (HP:0007730) | 1.81980348 |
| 176 | Renal cortical cysts (HP:0000803) | 1.80809807 |
| 177 | Hepatocellular necrosis (HP:0001404) | 1.80350210 |
| 178 | Decreased central vision (HP:0007663) | 1.80286346 |
| 179 | Inflammation of the large intestine (HP:0002037) | 1.80185084 |
| 180 | Recurrent abscess formation (HP:0002722) | 1.80074669 |
| 181 | Abnormality of the odontoid process (HP:0003310) | 1.79742258 |
| 182 | Colitis (HP:0002583) | 1.78697398 |
| 183 | Muscle fibrillation (HP:0010546) | 1.77871755 |
| 184 | High pitched voice (HP:0001620) | 1.77024289 |
| 185 | Inability to walk (HP:0002540) | 1.76539591 |
| 186 | Disinhibition (HP:0000734) | 1.76517777 |
| 187 | Cutaneous melanoma (HP:0012056) | 1.75333519 |
| 188 | Calcaneovalgus deformity (HP:0001848) | 1.74951377 |
| 189 | Increased CSF protein (HP:0002922) | 1.72172270 |
| 190 | Abnormality of the vertebral endplates (HP:0005106) | 1.70643376 |
| 191 | Mesangial abnormality (HP:0001966) | 1.70587554 |
| 192 | Cystic liver disease (HP:0006706) | 1.69416882 |
| 193 | Pustule (HP:0200039) | 1.67657486 |
| 194 | Abnormal urine output (HP:0012590) | 1.67158572 |
| 195 | Genetic anticipation (HP:0003743) | 1.67034288 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EIF2AK1 | 7.35345336 |
| 2 | FRK | 5.57155608 |
| 3 | TLK1 | 4.92013453 |
| 4 | ADRBK2 | 3.60984245 |
| 5 | MAP3K10 | 3.51869642 |
| 6 | ACVR1B | 3.19743848 |
| 7 | EEF2K | 2.94369362 |
| 8 | NME2 | 2.81166083 |
| 9 | PINK1 | 2.61995854 |
| 10 | DAPK2 | 2.59109298 |
| 11 | PKN2 | 2.58996662 |
| 12 | TXK | 2.43739143 |
| 13 | TEC | 2.32041504 |
| 14 | WNK4 | 2.30569676 |
| 15 | GRK1 | 2.28716290 |
| 16 | PIM2 | 2.24501992 |
| 17 | WEE1 | 2.18307787 |
| 18 | MAP3K9 | 2.17584915 |
| 19 | ZAK | 2.13431347 |
| 20 | GRK7 | 2.07210298 |
| 21 | FLT3 | 2.05770750 |
| 22 | BMPR1B | 2.02849235 |
| 23 | MAP4K2 | 1.96935835 |
| 24 | MAP4K1 | 1.90517305 |
| 25 | IKBKB | 1.82347060 |
| 26 | IRAK3 | 1.80496884 |
| 27 | BTK | 1.75419993 |
| 28 | MAPK13 | 1.71712769 |
| 29 | MAP3K3 | 1.67496363 |
| 30 | STK39 | 1.67417755 |
| 31 | KIT | 1.60285536 |
| 32 | STK24 | 1.59795135 |
| 33 | ERN1 | 1.54929656 |
| 34 | RPS6KA4 | 1.54225440 |
| 35 | INSRR | 1.51988313 |
| 36 | CDK12 | 1.43876598 |
| 37 | LRRK2 | 1.43027800 |
| 38 | TRIB3 | 1.36738451 |
| 39 | CSF1R | 1.34246275 |
| 40 | WNK3 | 1.34244400 |
| 41 | IKBKE | 1.31851540 |
| 42 | NUAK1 | 1.30784838 |
| 43 | MAP3K13 | 1.28740771 |
| 44 | STK16 | 1.28604683 |
| 45 | SYK | 1.28463666 |
| 46 | NEK2 | 1.27772819 |
| 47 | GRK6 | 1.23133121 |
| 48 | STK10 | 1.23059641 |
| 49 | TTN | 1.19393755 |
| 50 | FES | 1.18975958 |
| 51 | CDK19 | 1.18876663 |
| 52 | BUB1 | 1.16811260 |
| 53 | MAP3K14 | 1.16807600 |
| 54 | RAF1 | 1.14670885 |
| 55 | CCNB1 | 1.13082275 |
| 56 | RPS6KB2 | 1.12708924 |
| 57 | PTK2B | 1.03165739 |
| 58 | EPHA2 | 1.02667345 |
| 59 | PTK6 | 1.00009290 |
| 60 | ARAF | 0.97453619 |
| 61 | CAMKK2 | 0.96579019 |
| 62 | CSNK1G3 | 0.94857171 |
| 63 | TNK2 | 0.94017559 |
| 64 | SCYL2 | 0.93305579 |
| 65 | PRKCQ | 0.91142122 |
| 66 | ALK | 0.86866385 |
| 67 | ZAP70 | 0.86077255 |
| 68 | BRSK2 | 0.85061269 |
| 69 | ADRBK1 | 0.83267584 |
| 70 | CSNK1G1 | 0.83053734 |
| 71 | OXSR1 | 0.82385258 |
| 72 | CSNK1G2 | 0.81323256 |
| 73 | IRAK4 | 0.80102038 |
| 74 | CDC7 | 0.79361744 |
| 75 | TGFBR2 | 0.78938823 |
| 76 | IRAK1 | 0.78503112 |
| 77 | FGFR4 | 0.77749027 |
| 78 | CAMKK1 | 0.77385995 |
| 79 | MOS | 0.77072225 |
| 80 | BLK | 0.76461907 |
| 81 | MAP2K6 | 0.76293345 |
| 82 | MAPK4 | 0.75359739 |
| 83 | EPHB1 | 0.74640000 |
| 84 | PRKCE | 0.74408842 |
| 85 | MAPKAPK3 | 0.73785384 |
| 86 | DDR2 | 0.73468046 |
| 87 | CDK7 | 0.73312596 |
| 88 | TRPM7 | 0.70091452 |
| 89 | PIM1 | 0.69999866 |
| 90 | CSNK1A1L | 0.69757097 |
| 91 | ITK | 0.67329396 |
| 92 | BMPR2 | 0.67130446 |
| 93 | PAK2 | 0.63609897 |
| 94 | FER | 0.62746782 |
| 95 | HCK | 0.61789560 |
| 96 | BCKDK | 0.60500920 |
| 97 | MKNK1 | 0.60349016 |
| 98 | PASK | 0.59741070 |
| 99 | PAK4 | 0.58806870 |
| 100 | TYK2 | 0.58224102 |
| 101 | MATK | 0.57791628 |
| 102 | MAP3K8 | 0.57470093 |
| 103 | ABL2 | 0.57026717 |
| 104 | TAOK3 | 0.55734577 |
| 105 | PLK2 | 0.55323748 |
| 106 | DYRK3 | 0.54953886 |
| 107 | LYN | 0.53012985 |
| 108 | MAP3K2 | 0.52872648 |
| 109 | CDK4 | 0.51729902 |
| 110 | BRD4 | 0.50285241 |
| 111 | MKNK2 | 0.49244361 |
| 112 | RPS6KC1 | 0.49201520 |
| 113 | RPS6KL1 | 0.49201520 |
| 114 | RPS6KA6 | 0.49201341 |
| 115 | LCK | 0.48823691 |
| 116 | ERBB3 | 0.48691800 |
| 117 | HIPK2 | 0.48406629 |
| 118 | CDK6 | 0.46840822 |
| 119 | PRKG2 | 0.45865561 |
| 120 | MAPKAPK2 | 0.45470028 |
| 121 | PRKCI | 0.45351338 |
| 122 | PKN1 | 0.45145943 |
| 123 | MARK3 | 0.44390521 |
| 124 | SIK1 | 0.42401439 |
| 125 | MAP2K3 | 0.41648898 |
| 126 | ATR | 0.41206578 |
| 127 | CHUK | 0.40672141 |
| 128 | MAPKAPK5 | 0.40295866 |
| 129 | PRKCG | 0.40164295 |
| 130 | MAP2K1 | 0.39874329 |
| 131 | AURKB | 0.39804593 |
| 132 | MAP3K4 | 0.39619746 |
| 133 | DYRK1B | 0.39240895 |
| 134 | LMTK2 | 0.39046351 |
| 135 | PAK1 | 0.38541688 |
| 136 | PAK3 | 0.38391946 |
| 137 | TESK2 | 0.37968320 |
| 138 | DAPK1 | 0.37925633 |
| 139 | ABL1 | 0.37730532 |
| 140 | PDGFRA | 0.37642099 |
| 141 | TGFBR1 | 0.37256201 |
| 142 | MAPK11 | 0.37251711 |
| 143 | NEK1 | 0.36183976 |
| 144 | FGR | 0.35835550 |
| 145 | LIMK1 | 0.35695829 |
| 146 | CSK | 0.35425861 |
| 147 | IGF1R | 0.35251383 |
| 148 | TBK1 | 0.34720406 |
| 149 | JAK1 | 0.33570086 |
| 150 | GRK5 | 0.33304773 |
| 151 | JAK3 | 0.32962988 |
| 152 | CAMK4 | 0.32902026 |
| 153 | MAP3K7 | 0.32803884 |
| 154 | TNIK | 0.32626693 |
| 155 | MST4 | 0.32589749 |
| 156 | CSNK1A1 | 0.32221899 |
| 157 | STK4 | 0.31545573 |
| 158 | PRKCA | 0.31377891 |
| 159 | TAOK1 | 0.31306800 |
| 160 | MUSK | 0.31101089 |
| 161 | MAPK3 | 0.27316416 |
| 162 | JAK2 | 0.27098859 |
| 163 | EIF2AK3 | 0.26847894 |
| 164 | CDK9 | 0.26807005 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ribosome_Homo sapiens_hsa03010 | 4.23947313 |
| 2 | DNA replication_Homo sapiens_hsa03030 | 4.19363206 |
| 3 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 3.59033464 |
| 4 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.09393339 |
| 5 | Asthma_Homo sapiens_hsa05310 | 3.03007590 |
| 6 | Non-homologous end-joining_Homo sapiens_hsa03450 | 3.00577715 |
| 7 | Mismatch repair_Homo sapiens_hsa03430 | 2.99379046 |
| 8 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.81021567 |
| 9 | Allograft rejection_Homo sapiens_hsa05330 | 2.63172039 |
| 10 | Lysosome_Homo sapiens_hsa04142 | 2.52553007 |
| 11 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.39570558 |
| 12 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.38266518 |
| 13 | Homologous recombination_Homo sapiens_hsa03440 | 2.33352214 |
| 14 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.32421019 |
| 15 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.31036730 |
| 16 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 2.27914986 |
| 17 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.23270843 |
| 18 | Platelet activation_Homo sapiens_hsa04611 | 2.14941021 |
| 19 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.09508718 |
| 20 | p53 signaling pathway_Homo sapiens_hsa04115 | 2.05348588 |
| 21 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 2.05235993 |
| 22 | Base excision repair_Homo sapiens_hsa03410 | 2.04024421 |
| 23 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.95471705 |
| 24 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.93517685 |
| 25 | Cell cycle_Homo sapiens_hsa04110 | 1.86080808 |
| 26 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.82174587 |
| 27 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.81982457 |
| 28 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.73883762 |
| 29 | Leishmaniasis_Homo sapiens_hsa05140 | 1.71656689 |
| 30 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.71632205 |
| 31 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.70523332 |
| 32 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.66264278 |
| 33 | Phototransduction_Homo sapiens_hsa04744 | 1.62530293 |
| 34 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.52933847 |
| 35 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.50029552 |
| 36 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.49045251 |
| 37 | Other glycan degradation_Homo sapiens_hsa00511 | 1.45391730 |
| 38 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.43324384 |
| 39 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.41497361 |
| 40 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.41097589 |
| 41 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.40513001 |
| 42 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.39394164 |
| 43 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.38355718 |
| 44 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.36787153 |
| 45 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.35868582 |
| 46 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.34778633 |
| 47 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.31491165 |
| 48 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.29586126 |
| 49 | Shigellosis_Homo sapiens_hsa05131 | 1.24336562 |
| 50 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.24129966 |
| 51 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.20808956 |
| 52 | Alcoholism_Homo sapiens_hsa05034 | 1.16656468 |
| 53 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.15854003 |
| 54 | Measles_Homo sapiens_hsa05162 | 1.14238175 |
| 55 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.14066453 |
| 56 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.10557569 |
| 57 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.09135136 |
| 58 | Phagosome_Homo sapiens_hsa04145 | 1.08263489 |
| 59 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.07721213 |
| 60 | Hepatitis B_Homo sapiens_hsa05161 | 1.06294210 |
| 61 | Colorectal cancer_Homo sapiens_hsa05210 | 1.05651696 |
| 62 | Spliceosome_Homo sapiens_hsa03040 | 1.04097361 |
| 63 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.03609537 |
| 64 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.02030922 |
| 65 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.02001417 |
| 66 | Legionellosis_Homo sapiens_hsa05134 | 1.00909413 |
| 67 | Apoptosis_Homo sapiens_hsa04210 | 0.99941290 |
| 68 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.99834369 |
| 69 | Mineral absorption_Homo sapiens_hsa04978 | 0.99136569 |
| 70 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.98346502 |
| 71 | Thyroid cancer_Homo sapiens_hsa05216 | 0.96156252 |
| 72 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.95510339 |
| 73 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.95493213 |
| 74 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.94285478 |
| 75 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.93721999 |
| 76 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.92294529 |
| 77 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.92011907 |
| 78 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.90913215 |
| 79 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.90585427 |
| 80 | Pertussis_Homo sapiens_hsa05133 | 0.90103939 |
| 81 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.89842986 |
| 82 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.88204245 |
| 83 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.87471006 |
| 84 | Peroxisome_Homo sapiens_hsa04146 | 0.87342349 |
| 85 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.87020537 |
| 86 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.86250226 |
| 87 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.85394995 |
| 88 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.85250246 |
| 89 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.84550275 |
| 90 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.83101116 |
| 91 | Influenza A_Homo sapiens_hsa05164 | 0.82620181 |
| 92 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.79173936 |
| 93 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.78963522 |
| 94 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.78654263 |
| 95 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.78573424 |
| 96 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.78447010 |
| 97 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.75811810 |
| 98 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.75726935 |
| 99 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.75438276 |
| 100 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.74564728 |
| 101 | ABC transporters_Homo sapiens_hsa02010 | 0.74513037 |
| 102 | Tuberculosis_Homo sapiens_hsa05152 | 0.73831263 |
| 103 | RNA polymerase_Homo sapiens_hsa03020 | 0.73223253 |
| 104 | Salmonella infection_Homo sapiens_hsa05132 | 0.72145365 |
| 105 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.72025908 |
| 106 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.71574195 |
| 107 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.71153276 |
| 108 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.70993277 |
| 109 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.69981841 |
| 110 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.69881323 |
| 111 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.69669889 |
| 112 | HTLV-I infection_Homo sapiens_hsa05166 | 0.69434683 |
| 113 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.69133095 |
| 114 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.69130069 |
| 115 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.68106189 |
| 116 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.67642734 |
| 117 | Malaria_Homo sapiens_hsa05144 | 0.65501779 |
| 118 | Salivary secretion_Homo sapiens_hsa04970 | 0.64511801 |
| 119 | Focal adhesion_Homo sapiens_hsa04510 | 0.64087555 |
| 120 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.62887184 |
| 121 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.62876652 |
| 122 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.62435690 |
| 123 | Morphine addiction_Homo sapiens_hsa05032 | 0.62241986 |
| 124 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.61742114 |
| 125 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.61377863 |
| 126 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.60140920 |
| 127 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.59676919 |
| 128 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.59180369 |
| 129 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.57342197 |
| 130 | Sulfur relay system_Homo sapiens_hsa04122 | 0.55868913 |
| 131 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.54644630 |
| 132 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.53420926 |
| 133 | Olfactory transduction_Homo sapiens_hsa04740 | 0.52606697 |
| 134 | Hepatitis C_Homo sapiens_hsa05160 | 0.49250305 |
| 135 | Bladder cancer_Homo sapiens_hsa05219 | 0.48770470 |
| 136 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.48167526 |
| 137 | Viral myocarditis_Homo sapiens_hsa05416 | 0.48105605 |
| 138 | Taste transduction_Homo sapiens_hsa04742 | 0.46631634 |
| 139 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.45116758 |
| 140 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.44789799 |
| 141 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.43660080 |
| 142 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.43622374 |
| 143 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.42644791 |
| 144 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.41884269 |
| 145 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.40601901 |
| 146 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.40582396 |
| 147 | Amoebiasis_Homo sapiens_hsa05146 | 0.40253990 |
| 148 | Pathways in cancer_Homo sapiens_hsa05200 | 0.39292321 |
| 149 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.39014646 |
| 150 | Retinol metabolism_Homo sapiens_hsa00830 | 0.36449892 |
| 151 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.36063984 |
| 152 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.35517805 |
| 153 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.35474959 |
| 154 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.35190802 |
| 155 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.33883730 |
| 156 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.33526013 |
| 157 | Glioma_Homo sapiens_hsa05214 | 0.33063687 |
| 158 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.33033566 |
| 159 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.30511208 |
| 160 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.29255598 |
| 161 | Purine metabolism_Homo sapiens_hsa00230 | 0.28790600 |
| 162 | Basal transcription factors_Homo sapiens_hsa03022 | 0.28772654 |
| 163 | Renin secretion_Homo sapiens_hsa04924 | 0.27867924 |
| 164 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.27110752 |
| 165 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.27011755 |
| 166 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.26887037 |
| 167 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.26576135 |

